カテゴリ： 世界, 医療/バイオ, Market Monitor Global

一次抗体のグローバル市場展望 2023年-2029年：ポリクローナル、モノクローナル

■ 英語タイトル：Primary Antibodies Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8601）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8601
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：113
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[一次抗体のグローバル市場展望 2023年-2029年：ポリクローナル、モノクローナル]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の一次抗体市場規模と予測を収録しています。・世界の一次抗体市場：売上、2018年-2023年、2024年-2029年
・世界の一次抗体市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の一次抗体市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ポリクローナル」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

一次抗体のグローバル主要企業は、Abcam、 BD、 Santa Cruz Biotechnology、 Sigma Aldrich Corporation、 Thermo Fisher Scientific、 Bio-Rad、 R&D Systems、 MBL、 CST、 Merk、 Novus Biologicals、 PeproTech、 Cayman、 AbMax Biotechnology、 MABTech、 KPL、 Abnovaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、一次抗体のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の一次抗体市場：タイプ別、2018年-2023年、2024年-2029年
世界の一次抗体市場：タイプ別市場シェア、2022年
・ポリクローナル、モノクローナル

世界の一次抗体市場：用途別、2018年-2023年、2024年-2029年
世界の一次抗体市場：用途別市場シェア、2022年
・ELISA、ウェスタンブロット、免疫染色、免疫組織化学、免疫細胞化学、その他

世界の一次抗体市場：地域・国別、2018年-2023年、2024年-2029年
世界の一次抗体市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における一次抗体のグローバル売上、2018年-2023年
・主要企業における一次抗体のグローバル売上シェア、2022年
・主要企業における一次抗体のグローバル販売量、2018年-2023年
・主要企業における一次抗体のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Abcam、 BD、 Santa Cruz Biotechnology、 Sigma Aldrich Corporation、 Thermo Fisher Scientific、 Bio-Rad、 R&D Systems、 MBL、 CST、 Merk、 Novus Biologicals、 PeproTech、 Cayman、 AbMax Biotechnology、 MABTech、 KPL、 Abnova

*************************************************************

・調査・分析レポートの概要
一次抗体市場の定義
市場セグメント
世界の一次抗体市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の一次抗体市場規模
世界の一次抗体市場規模：2022年 VS 2029年
世界の一次抗体市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの一次抗体の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の一次抗体製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ポリクローナル、モノクローナル
一次抗体のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：ELISA、ウェスタンブロット、免疫染色、免疫組織化学、免疫細胞化学、その他
一次抗体の用途別グローバル売上・予測

・地域別市場分析
地域別一次抗体市場規模 2022年と2029年
地域別一次抗体売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Abcam、 BD、 Santa Cruz Biotechnology、 Sigma Aldrich Corporation、 Thermo Fisher Scientific、 Bio-Rad、 R&D Systems、 MBL、 CST、 Merk、 Novus Biologicals、 PeproTech、 Cayman、 AbMax Biotechnology、 MABTech、 KPL、 Abnova
...

This report aims to provide a comprehensive presentation of the global market for Primary Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Primary Antibodies. This report contains market size and forecasts of Primary Antibodies in global, including the following market information:
Global Primary Antibodies Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Primary Antibodies Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Primary Antibodies companies in 2022 (%)
The global Primary Antibodies market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Polyclonal Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Primary Antibodies include Abcam, BD, Santa Cruz Biotechnology, Sigma Aldrich Corporation, Thermo Fisher Scientific, Bio-Rad, R&D Systems, MBL and CST, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Primary Antibodies manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Primary Antibodies Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Primary Antibodies Market Segment Percentages, by Type, 2022 (%)
Polyclonal
Monoclonal
Global Primary Antibodies Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Primary Antibodies Market Segment Percentages, by Application, 2022 (%)
ELISA
Western Blot
Immunostaining
Immunohistochemistry
Immunocytochemistry
Other
Global Primary Antibodies Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Primary Antibodies Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Primary Antibodies revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Primary Antibodies revenues share in global market, 2022 (%)
Key companies Primary Antibodies sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Primary Antibodies sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abcam
BD
Santa Cruz Biotechnology
Sigma Aldrich Corporation
Thermo Fisher Scientific
Bio-Rad
R&D Systems
MBL
CST
Merk
Novus Biologicals
PeproTech
Cayman
AbMax Biotechnology
MABTech
KPL
Abnova
Outline of Major Chapters:
Chapter 1: Introduces the definition of Primary Antibodies, market overview.
Chapter 2: Global Primary Antibodies market size in revenue and volume.
Chapter 3: Detailed analysis of Primary Antibodies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Primary Antibodies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Primary Antibodies capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Primary Antibodies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Primary Antibodies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Primary Antibodies Overall Market Size
2.1 Global Primary Antibodies Market Size: 2022 VS 2029
2.2 Global Primary Antibodies Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Primary Antibodies Sales: 2018-2029
3 Company Landscape
3.1 Top Primary Antibodies Players in Global Market
3.2 Top Global Primary Antibodies Companies Ranked by Revenue
3.3 Global Primary Antibodies Revenue by Companies
3.4 Global Primary Antibodies Sales by Companies
3.5 Global Primary Antibodies Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Primary Antibodies Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Primary Antibodies Product Type
3.8 Tier 1, Tier 2 and Tier 3 Primary Antibodies Players in Global Market
3.8.1 List of Global Tier 1 Primary Antibodies Companies
3.8.2 List of Global Tier 2 and Tier 3 Primary Antibodies Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Primary Antibodies Market Size Markets, 2022 & 2029
4.1.2 Polyclonal
4.1.3 Monoclonal
4.2 By Type – Global Primary Antibodies Revenue & Forecasts
4.2.1 By Type – Global Primary Antibodies Revenue, 2018-2023
4.2.2 By Type – Global Primary Antibodies Revenue, 2024-2029
4.2.3 By Type – Global Primary Antibodies Revenue Market Share, 2018-2029
4.3 By Type – Global Primary Antibodies Sales & Forecasts
4.3.1 By Type – Global Primary Antibodies Sales, 2018-2023
4.3.2 By Type – Global Primary Antibodies Sales, 2024-2029
4.3.3 By Type – Global Primary Antibodies Sales Market Share, 2018-2029
4.4 By Type – Global Primary Antibodies Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Primary Antibodies Market Size, 2022 & 2029
5.1.2 ELISA
5.1.3 Western Blot
5.1.4 Immunostaining
5.1.5 Immunohistochemistry
5.1.6 Immunocytochemistry
5.1.7 Other
5.2 By Application – Global Primary Antibodies Revenue & Forecasts
5.2.1 By Application – Global Primary Antibodies Revenue, 2018-2023
5.2.2 By Application – Global Primary Antibodies Revenue, 2024-2029
5.2.3 By Application – Global Primary Antibodies Revenue Market Share, 2018-2029
5.3 By Application – Global Primary Antibodies Sales & Forecasts
5.3.1 By Application – Global Primary Antibodies Sales, 2018-2023
5.3.2 By Application – Global Primary Antibodies Sales, 2024-2029
5.3.3 By Application – Global Primary Antibodies Sales Market Share, 2018-2029
5.4 By Application – Global Primary Antibodies Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Primary Antibodies Market Size, 2022 & 2029
6.2 By Region – Global Primary Antibodies Revenue & Forecasts
6.2.1 By Region – Global Primary Antibodies Revenue, 2018-2023
6.2.2 By Region – Global Primary Antibodies Revenue, 2024-2029
6.2.3 By Region – Global Primary Antibodies Revenue Market Share, 2018-2029
6.3 By Region – Global Primary Antibodies Sales & Forecasts
6.3.1 By Region – Global Primary Antibodies Sales, 2018-2023
6.3.2 By Region – Global Primary Antibodies Sales, 2024-2029
6.3.3 By Region – Global Primary Antibodies Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Primary Antibodies Revenue, 2018-2029
6.4.2 By Country – North America Primary Antibodies Sales, 2018-2029
6.4.3 US Primary Antibodies Market Size, 2018-2029
6.4.4 Canada Primary Antibodies Market Size, 2018-2029
6.4.5 Mexico Primary Antibodies Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Primary Antibodies Revenue, 2018-2029
6.5.2 By Country – Europe Primary Antibodies Sales, 2018-2029
6.5.3 Germany Primary Antibodies Market Size, 2018-2029
6.5.4 France Primary Antibodies Market Size, 2018-2029
6.5.5 U.K. Primary Antibodies Market Size, 2018-2029
6.5.6 Italy Primary Antibodies Market Size, 2018-2029
6.5.7 Russia Primary Antibodies Market Size, 2018-2029
6.5.8 Nordic Countries Primary Antibodies Market Size, 2018-2029
6.5.9 Benelux Primary Antibodies Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Primary Antibodies Revenue, 2018-2029
6.6.2 By Region – Asia Primary Antibodies Sales, 2018-2029
6.6.3 China Primary Antibodies Market Size, 2018-2029
6.6.4 Japan Primary Antibodies Market Size, 2018-2029
6.6.5 South Korea Primary Antibodies Market Size, 2018-2029
6.6.6 Southeast Asia Primary Antibodies Market Size, 2018-2029
6.6.7 India Primary Antibodies Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Primary Antibodies Revenue, 2018-2029
6.7.2 By Country – South America Primary Antibodies Sales, 2018-2029
6.7.3 Brazil Primary Antibodies Market Size, 2018-2029
6.7.4 Argentina Primary Antibodies Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Primary Antibodies Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Primary Antibodies Sales, 2018-2029
6.8.3 Turkey Primary Antibodies Market Size, 2018-2029
6.8.4 Israel Primary Antibodies Market Size, 2018-2029
6.8.5 Saudi Arabia Primary Antibodies Market Size, 2018-2029
6.8.6 UAE Primary Antibodies Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Abcam
7.1.1 Abcam Company Summary
7.1.2 Abcam Business Overview
7.1.3 Abcam Primary Antibodies Major Product Offerings
7.1.4 Abcam Primary Antibodies Sales and Revenue in Global (2018-2023)
7.1.5 Abcam Key News & Latest Developments
7.2 BD
7.2.1 BD Company Summary
7.2.2 BD Business Overview
7.2.3 BD Primary Antibodies Major Product Offerings
7.2.4 BD Primary Antibodies Sales and Revenue in Global (2018-2023)
7.2.5 BD Key News & Latest Developments
7.3 Santa Cruz Biotechnology
7.3.1 Santa Cruz Biotechnology Company Summary
7.3.2 Santa Cruz Biotechnology Business Overview
7.3.3 Santa Cruz Biotechnology Primary Antibodies Major Product Offerings
7.3.4 Santa Cruz Biotechnology Primary Antibodies Sales and Revenue in Global (2018-2023)
7.3.5 Santa Cruz Biotechnology Key News & Latest Developments
7.4 Sigma Aldrich Corporation
7.4.1 Sigma Aldrich Corporation Company Summary
7.4.2 Sigma Aldrich Corporation Business Overview
7.4.3 Sigma Aldrich Corporation Primary Antibodies Major Product Offerings
7.4.4 Sigma Aldrich Corporation Primary Antibodies Sales and Revenue in Global (2018-2023)
7.4.5 Sigma Aldrich Corporation Key News & Latest Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Company Summary
7.5.2 Thermo Fisher Scientific Business Overview
7.5.3 Thermo Fisher Scientific Primary Antibodies Major Product Offerings
7.5.4 Thermo Fisher Scientific Primary Antibodies Sales and Revenue in Global (2018-2023)
7.5.5 Thermo Fisher Scientific Key News & Latest Developments
7.6 Bio-Rad
7.6.1 Bio-Rad Company Summary
7.6.2 Bio-Rad Business Overview
7.6.3 Bio-Rad Primary Antibodies Major Product Offerings
7.6.4 Bio-Rad Primary Antibodies Sales and Revenue in Global (2018-2023)
7.6.5 Bio-Rad Key News & Latest Developments
7.7 R&D Systems
7.7.1 R&D Systems Company Summary
7.7.2 R&D Systems Business Overview
7.7.3 R&D Systems Primary Antibodies Major Product Offerings
7.7.4 R&D Systems Primary Antibodies Sales and Revenue in Global (2018-2023)
7.7.5 R&D Systems Key News & Latest Developments
7.8 MBL
7.8.1 MBL Company Summary
7.8.2 MBL Business Overview
7.8.3 MBL Primary Antibodies Major Product Offerings
7.8.4 MBL Primary Antibodies Sales and Revenue in Global (2018-2023)
7.8.5 MBL Key News & Latest Developments
7.9 CST
7.9.1 CST Company Summary
7.9.2 CST Business Overview
7.9.3 CST Primary Antibodies Major Product Offerings
7.9.4 CST Primary Antibodies Sales and Revenue in Global (2018-2023)
7.9.5 CST Key News & Latest Developments
7.10 Merk
7.10.1 Merk Company Summary
7.10.2 Merk Business Overview
7.10.3 Merk Primary Antibodies Major Product Offerings
7.10.4 Merk Primary Antibodies Sales and Revenue in Global (2018-2023)
7.10.5 Merk Key News & Latest Developments
7.11 Novus Biologicals
7.11.1 Novus Biologicals Company Summary
7.11.2 Novus Biologicals Primary Antibodies Business Overview
7.11.3 Novus Biologicals Primary Antibodies Major Product Offerings
7.11.4 Novus Biologicals Primary Antibodies Sales and Revenue in Global (2018-2023)
7.11.5 Novus Biologicals Key News & Latest Developments
7.12 PeproTech
7.12.1 PeproTech Company Summary
7.12.2 PeproTech Primary Antibodies Business Overview
7.12.3 PeproTech Primary Antibodies Major Product Offerings
7.12.4 PeproTech Primary Antibodies Sales and Revenue in Global (2018-2023)
7.12.5 PeproTech Key News & Latest Developments
7.13 Cayman
7.13.1 Cayman Company Summary
7.13.2 Cayman Primary Antibodies Business Overview
7.13.3 Cayman Primary Antibodies Major Product Offerings
7.13.4 Cayman Primary Antibodies Sales and Revenue in Global (2018-2023)
7.13.5 Cayman Key News & Latest Developments
7.14 AbMax Biotechnology
7.14.1 AbMax Biotechnology Company Summary
7.14.2 AbMax Biotechnology Business Overview
7.14.3 AbMax Biotechnology Primary Antibodies Major Product Offerings
7.14.4 AbMax Biotechnology Primary Antibodies Sales and Revenue in Global (2018-2023)
7.14.5 AbMax Biotechnology Key News & Latest Developments
7.15 MABTech
7.15.1 MABTech Company Summary
7.15.2 MABTech Business Overview
7.15.3 MABTech Primary Antibodies Major Product Offerings
7.15.4 MABTech Primary Antibodies Sales and Revenue in Global (2018-2023)
7.15.5 MABTech Key News & Latest Developments
7.16 KPL
7.16.1 KPL Company Summary
7.16.2 KPL Business Overview
7.16.3 KPL Primary Antibodies Major Product Offerings
7.16.4 KPL Primary Antibodies Sales and Revenue in Global (2018-2023)
7.16.5 KPL Key News & Latest Developments
7.17 Abnova
7.17.1 Abnova Company Summary
7.17.2 Abnova Business Overview
7.17.3 Abnova Primary Antibodies Major Product Offerings
7.17.4 Abnova Primary Antibodies Sales and Revenue in Global (2018-2023)
7.17.5 Abnova Key News & Latest Developments
8 Global Primary Antibodies Production Capacity, Analysis
8.1 Global Primary Antibodies Production Capacity, 2018-2029
8.2 Primary Antibodies Production Capacity of Key Manufacturers in Global Market
8.3 Global Primary Antibodies Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Primary Antibodies Supply Chain Analysis
10.1 Primary Antibodies Industry Value Chain
10.2 Primary Antibodies Upstream Market
10.3 Primary Antibodies Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Primary Antibodies Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • CD161抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • ASL抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • TRIM21抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • PCK1抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • INTS3抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8601 )"一次抗体のグローバル市場展望 2023年-2029年：ポリクローナル、モノクローナル" (英文：Primary Antibodies Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。